GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (XTER:ACT) » Definitions » Cash Flow from Financing

AlzChem Group AG (XTER:ACT) Cash Flow from Financing : €-45.2 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AlzChem Group AG Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, AlzChem Group AG paid €0.0 Mil more to buy back shares than it received from issuing new shares. It received €0.0 Mil from issuing more debt. It paid €0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received €0.0 Mil from paying cash dividends to shareholders. It received €0.0 Mil on other financial activities. In all, AlzChem Group AG spent €0.0 Mil on financial activities for the three months ended in Mar. 2024.


AlzChem Group AG Cash Flow from Financing Historical Data

The historical data trend for AlzChem Group AG's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzChem Group AG Cash Flow from Financing Chart

AlzChem Group AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.17 -11.73 -23.62 33.65 -49.17

AlzChem Group AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.38 -24.43 8.00 -26.35 -2.42

AlzChem Group AG Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

AlzChem Group AG's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

AlzChem Group AG's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-45.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AlzChem Group AG  (XTER:ACT) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

AlzChem Group AG's issuance of stock for the three months ended in Mar. 2024 was €0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

AlzChem Group AG's repurchase of stock for the three months ended in Mar. 2024 was €0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

AlzChem Group AG's net issuance of debt for the three months ended in Mar. 2024 was €0.0 Mil. AlzChem Group AG received €0.0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

AlzChem Group AG's net issuance of preferred for the three months ended in Mar. 2024 was €0.0 Mil. AlzChem Group AG paid €0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

AlzChem Group AG's cash flow for dividends for the three months ended in Mar. 2024 was €0.0 Mil. AlzChem Group AG received €0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

AlzChem Group AG's other financing for the three months ended in Mar. 2024 was €0.0 Mil. AlzChem Group AG received €0.0 Mil on other financial activities.


AlzChem Group AG Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzChem Group AG (XTER:ACT) Business Description

Traded in Other Exchanges
Address
Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.

AlzChem Group AG (XTER:ACT) Headlines

From GuruFocus

Enact Receives Ratings Upgrade from Fitch Ratings

By sperokesalga sperokesalga 04-25-2023

Enact Announces Quarterly Dividend

By sperokesalga sperokesalga 02-09-2023

Enact To Participate at the Bank of America 2023 Financial Services Conference

By Stock market mentor Stock market mentor 02-03-2023

Enact Enters Into $200 Million Revolving Credit Facility

By GuruFocusNews GuruFocusNews 07-07-2022

Enact to Host Second Quarter 2022 Earnings Call August 2nd

By GuruFocusNews GuruFocusNews 07-08-2022

Enact Announces Quarterly Dividend

By Marketwired 08-15-2023